Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540)
South Korea
· Delayed Price · Currency is KRW
9,130.00
-70.00 (-0.76%)
At close: Dec 5, 2025
Ahn-Gook Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 103,766 | 74,216 | 106,948 | 104,448 | 122,613 | 148,969 | |
| Market Cap Growth | 28.77% | -30.61% | 2.39% | -14.82% | -17.69% | 20.93% | |
| Enterprise Value | 122,338 | 118,816 | 100,255 | 81,429 | 96,410 | 96,617 | |
| Last Close Price | 9130.00 | 6530.00 | 8790.18 | 8375.75 | 9529.41 | 11344.11 | |
| PE Ratio | 10.51 | 4.41 | 82.90 | 15.19 | 31.13 | - | |
| PS Ratio | 0.34 | 0.27 | 0.46 | 0.51 | 0.75 | 1.04 | |
| PB Ratio | 0.62 | 0.45 | 0.71 | 0.68 | 0.80 | 1.00 | |
| P/TBV Ratio | 0.63 | 0.46 | 0.72 | 0.69 | 0.82 | 1.02 | |
| P/FCF Ratio | 2.78 | - | - | - | - | - | |
| P/OCF Ratio | 2.40 | 15.10 | - | 58.40 | 83.29 | 13.31 | |
| EV/Sales Ratio | 0.41 | 0.44 | 0.43 | 0.40 | 0.59 | 0.67 | |
| EV/EBITDA Ratio | 5.08 | 8.27 | 9.94 | 5.69 | 28.16 | 20.85 | |
| EV/EBIT Ratio | 7.98 | 17.79 | 19.81 | 8.68 | - | - | |
| EV/FCF Ratio | 3.28 | - | - | - | - | - | |
| Debt / Equity Ratio | 0.44 | 0.47 | 0.12 | 0.13 | 0.13 | 0.14 | |
| Debt / EBITDA Ratio | 2.84 | 5.41 | 1.75 | 1.40 | 5.90 | 4.49 | |
| Debt / FCF Ratio | 1.95 | - | - | - | - | - | |
| Asset Turnover | 0.99 | 1.00 | 1.01 | 0.93 | 0.77 | 0.68 | |
| Inventory Turnover | 2.39 | 2.57 | 2.99 | 3.13 | 2.69 | 2.53 | |
| Quick Ratio | 1.16 | 1.15 | 1.25 | 1.53 | 1.75 | 1.89 | |
| Current Ratio | 1.79 | 1.75 | 1.73 | 1.98 | 2.23 | 2.49 | |
| Return on Equity (ROE) | 5.57% | 10.33% | 0.65% | 4.47% | 2.47% | -0.93% | |
| Return on Assets (ROA) | 3.49% | 1.54% | 1.37% | 2.64% | -0.32% | -0.01% | |
| Return on Capital (ROIC) | 4.38% | 2.03% | 1.84% | 3.37% | -0.39% | -0.02% | |
| Return on Capital Employed (ROCE) | 7.40% | 3.00% | 3.20% | 5.80% | -0.60% | 0.00% | |
| Earnings Yield | 9.52% | 22.70% | 1.21% | 6.58% | 3.21% | -0.88% | |
| FCF Yield | 35.95% | -95.63% | -6.36% | -1.09% | -2.09% | -8.68% | |
| Dividend Yield | 4.82% | 6.74% | - | - | - | - | |
| Payout Ratio | 50.62% | 14.84% | 193.81% | 36.52% | 64.00% | - | |
| Buyback Yield / Dilution | -0.00% | - | 0.12% | 0.65% | 9.44% | -10.37% | |
| Total Shareholder Return | 4.78% | 6.74% | 0.12% | 0.65% | 9.44% | -10.37% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.